EXECUTIVE SUMMARY

Executive Summary 

Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large "unmet need" in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and neurodegenerative diseases. The company’s proprietary and unique technology overcomes the major barriers to transplantation by a novel strategy utilizing patented micro-encapsulation technology, enabling a transplantable, cell-based therapy that avoids detection and rejection by the immune system.


Mission

Develop improved treatments specifically for diabetes and other chronic diseases using a novel type of therapeutic: implanted cells shielded by proprietary biomaterials from immune attack and the foreign body response (fibrosis). 


Vision

Apply Altucell’s cell engineering and delivery system-based platform to re-program and control dynamic protein delivery for the long-term treatment of debilitating diseases.